News

• New logo and website created to reflect Leaf’s progression

• Better user experience with in-depth information on services and R&D


Norwich, UK - 24 January 2023 Leaf Expression Systems (Leaf), a plant-based contract research and product development company working to serve the global life sciences (human and animal health), agribiotech, food and consumer care industries has launched a new logo and website, leafexpressionsystems.com.

The EU Commission launched the process regarding the adoption of an adequacy decision for EU-U.S. How the #adequacydecision for United States will improve #datatransfers between EU and U.S.?

Click here to view the January 2023 edition of The Meeting Place.






 

Monday 23rd January 2022: Creative Places is delighted to announce the appointment of Liam Nicholls to the position of CEO. Liam takes over from Jonathan Burroughs, who will remain fully involved in the business, focusing on client work.

o2h discovery, a preclinical Contract Research Organization which has an integrated drug discovery platform, is pleased to announce the second edition of the o2h kickstarter competition exclusively aimed towards supporting Australian early stage biotech companies. After the overwhelming response to the first competition, we are back with another edition to specifically support early stage Aus Biotech in their drug discovery programmes.


  • New company created to enable commercial manufacture of new cell and gene therapies

  • Cellular Origins’ proprietary technology will address current barriers associated with cost-effective and efficient manufacture of cell and gene therapies at scale


  • Expansion of five-year collaboration broadens established Organ-on-a-chip research demonstrating advanced performance of the PhysioMimix MPS

  • New research project to investigate the use of multi-organ MPS to improve estimation of human drug bioavailability in comparison to existing animal models





 

Howard Group appoints Hilson Moran as Sustainability Consultant for its flagship development Unity Campus


         

Arecor Therapeutics plc

(“Arecor” or the “Group”)


ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA


License milestone to develop and commercialise ready-to-use medicine achieved


Arecor regains rights to AT282 following portfolio review at Hikma

Reddie & Grose, a UK and European firm of Patent, Trade Mark and Design attorneys, is delighted to announce that Dr Yumiko Kato has joined the firm as a Senior Associate. She will be working out of the London office.


Yumiko’s specialist field is chemistry where she holds particular experience in polymer chemistry, detergent compositions, printing ink compositions, material science, catalysis, nanotechnology and fluorocarbon chemistry. She also has extensive experience in pharmaceuticals and medical devices.

Pages